ELUT
Elutia Inc.NASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$46.56M
P/E Ratio
—
EPS
$-0.64
Beta
0.71
52W High
$2.64
52W Low
$0.50
50-Day MA
$1.11
200-Day MA
$1.16
Dividend Yield
—
Profit Margin
434.20%
Forward P/E
—
PEG Ratio
—
About Elutia Inc.
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. The company is headquartered in Silver Spring, Maryland.
Fundamentals
| Revenue (TTM) | $12.29M |
| Gross Profit (TTM) | $6.60M |
| EBITDA | $-17.20M |
| Operating Margin | -167.90% |
| Return on Equity | 0.00% |
| Return on Assets | -23.40% |
| Revenue/Share (TTM) | $0.30 |
| Book Value | $0.65 |
| Price-to-Book | 1.68 |
| Price-to-Sales (TTM) | 3.79 |
| EV/Revenue | 1.151 |
| EV/EBITDA | -3.33 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.20% |
| Shares Outstanding | $44.21M |
| Float | $24.89M |
| % Insiders | 2.94% |
| % Institutions | 47.63% |
Historical Volatility
HV 10-Day
43.09%
HV 20-Day
49.56%
HV 30-Day
50.30%
HV 60-Day
66.13%
HV Rank
9.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($5.00 target)
2
BuyData last updated: 4/29/2026